1. Home
  2. RRBI vs ALLO Comparison

RRBI vs ALLO Comparison

Compare RRBI & ALLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RRBI
  • ALLO
  • Stock Information
  • Founded
  • RRBI 1998
  • ALLO 2017
  • Country
  • RRBI United States
  • ALLO United States
  • Employees
  • RRBI N/A
  • ALLO N/A
  • Industry
  • RRBI Hotels/Resorts
  • ALLO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • RRBI Consumer Discretionary
  • ALLO Health Care
  • Exchange
  • RRBI Nasdaq
  • ALLO Nasdaq
  • Market Cap
  • RRBI 394.9M
  • ALLO 431.9M
  • IPO Year
  • RRBI 2019
  • ALLO 2018
  • Fundamental
  • Price
  • RRBI $55.48
  • ALLO $1.87
  • Analyst Decision
  • RRBI
  • ALLO Buy
  • Analyst Count
  • RRBI 0
  • ALLO 12
  • Target Price
  • RRBI N/A
  • ALLO $10.06
  • AVG Volume (30 Days)
  • RRBI 13.0K
  • ALLO 2.7M
  • Earning Date
  • RRBI 01-28-2025
  • ALLO 11-07-2024
  • Dividend Yield
  • RRBI 0.65%
  • ALLO N/A
  • EPS Growth
  • RRBI N/A
  • ALLO N/A
  • EPS
  • RRBI 4.75
  • ALLO N/A
  • Revenue
  • RRBI $106,383,000.00
  • ALLO $43,000.00
  • Revenue This Year
  • RRBI N/A
  • ALLO N/A
  • Revenue Next Year
  • RRBI $7.61
  • ALLO N/A
  • P/E Ratio
  • RRBI $11.68
  • ALLO N/A
  • Revenue Growth
  • RRBI N/A
  • ALLO 26.47
  • 52 Week Low
  • RRBI $42.78
  • ALLO $1.78
  • 52 Week High
  • RRBI $62.13
  • ALLO $5.78
  • Technical
  • Relative Strength Index (RSI)
  • RRBI 40.05
  • ALLO 36.24
  • Support Level
  • RRBI $57.65
  • ALLO $1.83
  • Resistance Level
  • RRBI $58.59
  • ALLO $2.12
  • Average True Range (ATR)
  • RRBI 1.95
  • ALLO 0.16
  • MACD
  • RRBI -0.83
  • ALLO -0.02
  • Stochastic Oscillator
  • RRBI 28.83
  • ALLO 12.16

About RRBI Red River Bancshares Inc.

Red River Bancshares Inc is the bank holding company for the red river bank. The principal business of the Bank is lending and accepting deposits from businesses, professionals, individuals, and public entities. The bank's primary deposit products are demand deposits, savings deposits, and time deposits. The bank maintains a diversified loan portfolio with a focus on commercial real estate (Owner Occupied and Non-Owner Occupied), one-to-four-family residential, commercial, and industrial loans, construction and development Loans, and others. also, provides Treasury Management Services, Private Banking Services, Brokerage Services, and Other Banking Services.

About ALLO Allogene Therapeutics Inc.

Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, primarily generated from collaborations and licensing agreements, supports their research and development efforts.

Share on Social Networks: